UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

MTN-001: randomized pharmacokinetic cross-over study comparing tenofovir vaginal gel and oral tablets in vaginal tissue and other compartments

PloS one, 2013-01, Vol.8 (1), p.e55013

2013

Volltextzugriff (PDF)

Phase 1 randomized trials to assess safety, pharmacokinetics, and vaginal bleeding associated with use of extended duration dapivirine and levonorgestrel vaginal rings

PloS one, 2024-06, Vol.19 (6), p.e0304552

2024

Volltextzugriff (PDF)

Acceptability of an extended duration vaginal ring for HIV prevention and interest in a multi-purpose ring

PloS one, 2022-02, Vol.17 (2), p.e0263664

2022

Volltextzugriff (PDF)

Changes in genital tract immune cell populations after initiation of intrauterine contraception

American journal of obstetrics and gynecology, 2014-11, Vol.211 (5), p.489.e1-489.e9

2014

Volltextzugriff (PDF)

Phase 1 randomized pharmacokinetic and safety study of a 90‐day tenofovir vaginal ring in the United States

Journal of the International AIDS Society, 2024-03, Vol.27 (3), p.e26223-n/a

2024

Volltextzugriff (PDF)

Safety and Pharmacokinetics of a Tenofovir Alafenamide Fumarate-Emtricitabine based Oral Antiretroviral Regimen for Prevention of HIV Acquisition in Women: A Randomized Controlled Trial

EClinicalMedicine, 2021-06, Vol.36, p.100893, Article 100893

2021

Volltextzugriff (PDF)

Participant experiences with a multipurpose vaginal ring for HIV and pregnancy prevention during a phase 1 clinical trial: learning from users to improve acceptability

Frontiers in reproductive health, 2023-07, Vol.5, p.1147628-1147628

2023

Volltextzugriff (PDF)

Continuation rates of two different-sized copper intrauterine devices among nulliparous women: Interim 12-month results of a single-blind, randomised, multicentre trial

EClinicalMedicine, 2022-09, Vol.51, p.101554-101554, Article 101554

2022

Volltextzugriff (PDF)

Society of Family Planning Guidelines: Postplacental insertion of intrauterine devices

Contraception (Stoneham), 2018-01, Vol.97 (1), p.2-13

2018

Volltextzugriff (PDF)

Levonorgestrel 52 mg intrauterine system efficacy and safety through 8 years of use

American journal of obstetrics and gynecology, 2022-12, Vol.227 (6), p.871.e1-871.e7

2022

Volltextzugriff (PDF)

Management of heterotopic pregnancy with uterine aspiration and systemic two-dose methotrexate

Contraception (Stoneham), 2021-10, Vol.104 (4), p.444-446

2021

Volltextzugriff (PDF)

Five-Year Contraceptive Efficacy and Safety of a Levonorgestrel 52-mg Intrauterine System

Obstetrics and gynecology (New York. 1953), 2019-01, Vol.133 (1), p.63-70

2019

Volltextzugriff (PDF)

The legal and medical necessity of abortion care amid the COVID-19 pandemic

Journal of law and the biosciences, 2020-01, Vol.7 (1), p.OO1-lsaa013

2020

Volltextzugriff (PDF)

Phase 1 Safety, Pharmacokinetics, and Pharmacodynamics of Dapivirine and Maraviroc Vaginal Rings: A Double-Blind Randomized Trial

Journal of acquired immune deficiency syndromes (1999), 2015-11, Vol.70 (3), p.242-249

2015

Volltextzugriff (PDF)

Corrigendum to ‘Levonorgestrel 52 mg intrauterine system efficacy and safety through 8 years of use’ [American Journal of Obstetrics and Gynecology 2022;227:871.e1-871.e7]

American journal of obstetrics and gynecology, 2023-09, Vol.229 (3), p.358-358

2023

Volltextzugriff (PDF)

Insertion-Related Pain and Short-Term Satisfaction With Two Copper IUDs: A Randomized Trial [22I]

Obstetrics and gynecology (New York. 1953), 2020-05, Vol.135 (1), p.97-97S

2020

Volltextzugriff (PDF)

Levonorgestrel 52-mg Intrauterine Device Efficacy and Safety After More Than 8 Years of Use

Obstetrics and gynecology (New York. 1953), 2023-05, Vol.141 (5), p.1004

2023

Volltextzugriff (PDF)

Early pregnancy confirmation availability at crisis pregnancy centers and abortion facilities in the United States

Contraception (Stoneham), 2023-01, Vol.117, p.30-35

2023

Volltextzugriff (PDF)

Bleeding changes after levonorgestrel 52-mg intrauterine system insertion for contraception in women with self-reported heavy menstrual bleeding

American journal of obstetrics and gynecology, 2020-04, Vol.222 (4), p.S888.e1-S888.e6

2020

Volltextzugriff (PDF)

Prenatal intent and postpartum receipt of long-acting reversible contraception among women receiving medication-assisted treatment for opioid use disorder

Contraception (Stoneham), 2019-01, Vol.99 (1), p.36-41

2019

Volltextzugriff (PDF)

Users' Preferred Characteristics of Vaginal Rings for HIV Prevention: A Qualitative Analysis of Two Phase I Trials

AIDS research and human retroviruses, 2022-04, Vol.38 (4), p.313-326

2022

Volltextzugriff (PDF)

Postplacental or delayed insertion of the levonorgestrel intrauterine device after vaginal delivery: a randomized controlled trial

Obstetrics and gynecology (New York. 1953), 2010-11, Vol.116 (5), p.1079-1087

2010

Volltextzugriff (PDF)

Phase 2a Safety, Pharmacokinetics, and Acceptability of Dapivirine Vaginal Rings in US Postmenopausal Women

Clinical infectious diseases, 2019-03, Vol.68 (7), p.1144-1151

2019

Volltextzugriff (PDF)

Adherence to Recommended Practices for Provision of Long-Acting Reversible Contraception Among Providers in a Large U.S. Health Care System

Journal of women's health (Larchmont, N.Y. 2002), 2020-12, Vol.29 (12), p.1586-1595

2020

Volltextzugriff (PDF)

Impact of Dapivirine and Placebo Vaginal Rings on the Microbiota of Adolescent, Lactating, and Postmenopausal Females

The Journal of infectious diseases, 2022-06, Vol.225 (12), p.2208-2218

2022

Volltextzugriff (PDF)

1 – 25 von 640

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(571)
Mit Volltextzugriff
(525)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(416)
Life Sciences & Biomedicine
(320)
Humans
(239)
Female
(144)
Male
(94)
Adult
(92)
Animals
(80)
Biological And Medical Sciences
(57)
Middle Aged
(53)
Technology
(52)
Adolescent
(48)
Immunology
(48)
Science & Technology - Other Topics
(47)
Infectious Diseases
(45)
Medical Sciences
(43)
Oncology
(43)
Mice
(41)
Young Adult
(41)
Multidisciplinary Sciences
(40)
Physical Sciences
(36)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(16)
... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

MTN-001: randomized pharmacokinetic cross-over study comparing tenofovir vaginal gel and oral tablets in vaginal tissue and other compartments

Phase 1 randomized trials to assess safety, pharmacokinetics, and vaginal bleeding associated with use of extended duration dapivirine and levonorgestrel vaginal rings

Acceptability of an extended duration vaginal ring for HIV prevention and interest in a multi-purpose ring

Changes in genital tract immune cell populations after initiation of intrauterine contraception

Phase 1 randomized pharmacokinetic and safety study of a 90‐day tenofovir vaginal ring in the United States

Safety and Pharmacokinetics of a Tenofovir Alafenamide Fumarate-Emtricitabine based Oral Antiretroviral Regimen for Prevention of HIV Acquisition in Women: A Randomized Controlled Trial

Participant experiences with a multipurpose vaginal ring for HIV and pregnancy prevention during a phase 1 clinical trial: learning from users to improve acceptability

Continuation rates of two different-sized copper intrauterine devices among nulliparous women: Interim 12-month results of a single-blind, randomised, multicentre trial

Society of Family Planning Guidelines: Postplacental insertion of intrauterine devices

Levonorgestrel 52 mg intrauterine system efficacy and safety through 8 years of use

Management of heterotopic pregnancy with uterine aspiration and systemic two-dose methotrexate

Five-Year Contraceptive Efficacy and Safety of a Levonorgestrel 52-mg Intrauterine System

The legal and medical necessity of abortion care amid the COVID-19 pandemic

Phase 1 Safety, Pharmacokinetics, and Pharmacodynamics of Dapivirine and Maraviroc Vaginal Rings: A Double-Blind Randomized Trial

Corrigendum to ‘Levonorgestrel 52 mg intrauterine system efficacy and safety through 8 years of use’ [American Journal of Obstetrics and Gynecology 2022;227:871.e1-871.e7]

Insertion-Related Pain and Short-Term Satisfaction With Two Copper IUDs: A Randomized Trial [22I]

Levonorgestrel 52-mg Intrauterine Device Efficacy and Safety After More Than 8 Years of Use

Early pregnancy confirmation availability at crisis pregnancy centers and abortion facilities in the United States

Bleeding changes after levonorgestrel 52-mg intrauterine system insertion for contraception in women with self-reported heavy menstrual bleeding

Prenatal intent and postpartum receipt of long-acting reversible contraception among women receiving medication-assisted treatment for opioid use disorder

Users' Preferred Characteristics of Vaginal Rings for HIV Prevention: A Qualitative Analysis of Two Phase I Trials

Postplacental or delayed insertion of the levonorgestrel intrauterine device after vaginal delivery: a randomized controlled trial

Phase 2a Safety, Pharmacokinetics, and Acceptability of Dapivirine Vaginal Rings in US Postmenopausal Women

Adherence to Recommended Practices for Provision of Long-Acting Reversible Contraception Among Providers in a Large U.S. Health Care System

Impact of Dapivirine and Placebo Vaginal Rings on the Microbiota of Adolescent, Lactating, and Postmenopausal Females

Suchergebnisse filtern